Cipla share price hit a new record high of Rs 997.20 apiece in intraday on BSE on Wednesday, after the DCGI approved the firm to import Moderna, a Covid-19 vaccine, with emergency use authorisation in India.
With Sputnik V covid-19 vaccine getting the Emergency Use Authorisation (EUA), Dr Reddy’s Laboratories stands to benefit after having secured exclusive marketing and distribution rights for the first 250 million doses of th
Dr. Reddy's Laboratories shares have rallied 15.55 per cent, in comparison, S&P BSE Sensex gained just 1.14 per cent. The company announced the settlement of US Revlimid® (lenalidomide) capsules patent litigation with Celgen
Dr Reddy's Laboratories has inked a pact with Teva Pharmaceutical and an affiliate of Allergan Plc to buy a portfolio of eight abbreviated new drug applications (ANDAs) in the US for $ 350 million (around Rs 2,300 crore) in c
The US Consumer Product Safety Commission (US CPSC) has approached the US Department of Justice seeking action against Dr Reddy's Laboratories in a 5-year old case involving packaging for five blister-packed prescription prod
Dr Reddy's Laboratories shares plunged as much as 2.24 per cent on Thursday after reports that the US Consumer Product Safety Commission charges company for packaging lapses in at least five prescription drugs.